Aetna Inc (AET) Shares Sold by CENTRAL TRUST Co

CENTRAL TRUST Co lessened its holdings in Aetna Inc (NYSE:AET) by 23.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 11,666 shares of the company’s stock after selling 3,611 shares during the quarter. CENTRAL TRUST Co’s holdings in Aetna were worth $2,104,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in AET. Janus Henderson Group PLC boosted its stake in shares of Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after buying an additional 4,283,553 shares during the last quarter. Capital World Investors boosted its stake in shares of Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after buying an additional 1,688,767 shares during the last quarter. Orbimed Advisors LLC boosted its stake in shares of Aetna by 57.3% in the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after buying an additional 508,600 shares during the last quarter. Samlyn Capital LLC purchased a new position in shares of Aetna in the 2nd quarter worth approximately $77,170,000. Finally, Point72 Asset Management L.P. boosted its stake in shares of Aetna by 233.9% in the 3rd quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock worth $68,271,000 after buying an additional 300,753 shares during the last quarter. Hedge funds and other institutional investors own 87.88% of the company’s stock.

Shares of Aetna Inc (AET) opened at $189.31 on Wednesday. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc has a 1-year low of $116.04 and a 1-year high of $192.37. The stock has a market cap of $61,730.00, a price-to-earnings ratio of 34.99, a price-to-earnings-growth ratio of 1.59 and a beta of 0.61.

Aetna (NYSE:AET) last issued its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same quarter in the previous year, the firm posted $2.07 EPS. The business’s revenue for the quarter was down 5.0% compared to the same quarter last year. equities research analysts forecast that Aetna Inc will post 9.78 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be issued a dividend of $0.50 per share. The ex-dividend date is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.06%. Aetna’s payout ratio is 36.97%.

A number of brokerages have recently weighed in on AET. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and boosted their target price for the stock from $195.00 to $212.00 in a research note on Monday. Zacks Investment Research cut shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $175.00 price target on shares of Aetna in a report on Monday, October 23rd. Citigroup lifted their price target on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, November 2nd. Finally, Piper Jaffray Companies raised shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target on the stock in a report on Wednesday, January 3rd. Eleven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Aetna has an average rating of “Buy” and an average target price of $175.09.

ILLEGAL ACTIVITY WARNING: This piece was reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.com-unik.info/2018/01/24/aetna-inc-aet-shares-sold-by-central-trust-co.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit